InvestorsHub Logo
Followers 37
Posts 7210
Boards Moderated 1
Alias Born 09/06/2014

Re: Miamifl post# 329008

Saturday, 05/04/2024 9:21:05 AM

Saturday, May 04, 2024 9:21:05 AM

Post# of 333420
Kelly needs to accept responsibility for the share price.

"Negative speculation" on a stock message board isn't "harming" the share price. Lack of revenues, lack of funding, lack of R&D accomplishments and activity, the loss of patent protection, and a bloated share structure harm the company's share price.

A real CEO could possibly make a success out of this company but what are the chances of ever getting a real CEO here?

There are some positives here: a couple of independent researchers are doing good work that might help the company in the future, and the NOPAIN Act might create some revenues in 2025. But without professional management and without patent protection, this little company is going to remain a little company, barely eking out an existence.

Losing the patents -- cripes. It's hard to even fathom. It's been almost three years since she bungled that. Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 07/26/2021

https://patentcenter.uspto.gov/applications/10384101

Without IP protection, there isn't even a legitimate "buyout rumor" here -- the last-ditch pump of every zombie biotech. Nobody buys a zombie biotech that has no IP protection. There's nothing to buy here but a barely-recognized brand name.